![](/img/cover-not-exists.png)
Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia
Ester M. Orlandi, Barbara Rocca, Anna S. Pazzano, Stefano GhioVolume:
36
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.leukres.2011.08.007
File:
PDF, 609 KB
english, 2012